NCT02109107

Brief Summary

The purpose of this study is to determine whether low level laser light therapy is effective in reducing circumference of the waist, hips, thighs and upper abdomen over a 6 week period.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2013

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2013

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

April 7, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 9, 2014

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2014

Completed
1.3 years until next milestone

Results Posted

Study results publicly available

February 2, 2016

Completed
Last Updated

February 2, 2016

Status Verified

December 1, 2015

Enrollment Period

1.1 years

First QC Date

April 7, 2014

Results QC Date

December 31, 2015

Last Update Submit

December 31, 2015

Conditions

Keywords

body contouringbody shapingcircumference reduction

Outcome Measures

Primary Outcomes (1)

  • Change in Combined Circumference Measurements

    Combined circumference measurement is calculated as the sum of the measurements for the individual body areas of the right and left thighs, hips, waist and upper abdomen. Change in combined circumference measurements is calculated as the difference in measurements from baseline to after completion of the 6-week procedure administration period. A negative (-) change indicates a reduction in combined circumference measurement across the evaluation period and is positive for study success. A positive (+) change indicates an increase in combined circumference measurements across the evaluation period and is negative for study success. A mean change for the study subject group of -3.0 inches or more in combined circumference measurements will be considered a clinically meaningful and statistically significant positive change indicative of study success.

    Baseline and 6 weeks

Secondary Outcomes (3)

  • Change in Body Weight

    Baseline and 6 weeks

  • Change in Body Mass Index (BMI)

    Baseline and 6 weeks

  • Subject Satisfaction With Study Outcome Rating

    6 weeks

Study Arms (1)

Erchonia EZ6 Laser

EXPERIMENTAL

The Erchonia EZ6 Laser is a 6 headed scanner composed of 6 independent 17 milliWatts (mW), 635 nanometer (nm) red laser diodes mounted in scanner devices. It is a variable frequency, pulsed wave laser device.

Device: Erchonia EZ6 Laser

Interventions

The Erchonia EZ6 is administered 6 times across 6 consecutive weeks, each administration seven days apart, each treatment lasting 60 minutes.

Also known as: Erchonia® Zerona 6 Headed Scanner
Erchonia EZ6 Laser

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Body Mass Index (BMI) between 25 kg/m² and 40 kg/m²
  • Subject indicated for liposuction or use of liposuction techniques for the removal of localized deposits of adipose tissues that do not respond to diet and exercise for the hips, waist, thighs and upper abdomen. (As per the American Academy of Cosmetic Surgery's 2006 Guidelines for Liposuction Surgery developed by A joint Ad Hoc Committee of the American Society of Lipo-Suction Surgery (ASLSS) and the American Academy of Cosmetic Surgery (AACS))
  • Willing and able to abstain from treatments other than the study procedure for body contouring/circumference reduction/weight loss during study participation
  • Willing and able to maintain typical diet and exercise regimen during study participation

You may not qualify if:

  • Body Mass Index (BMI) less than 25 kg/m² or greater than 40 kg/m²
  • Known cardiovascular disease
  • Cardiac surgeries such as bypass, heart transplant surgery, pacemakers
  • Prior surgical intervention for body sculpting/weight loss
  • Medical, physical, or other contraindications for body sculpting/weight loss
  • Current use of medication known to affect weight levels/cause bloating or swelling and for which abstinence during study participation is not possible
  • Any medical condition known to affect weight levels and/or cause bloating or swelling.
  • Diagnosis of, and/or taking medication for, irritable bowel syndrome.
  • Active infection, wound or other external trauma to the study treatment areas
  • Known photosensitivity disorder
  • Active cancer or currently receiving treatment for cancer
  • Pregnant or planning pregnancy prior to study participation end
  • Serious mental health illness such as dementia/schizophrenia; psychiatric hospitalization in past two years.
  • Developmental disability or cognitive impairment that may preclude adequate comprehension of the consent form and/or ability to record the study measures
  • Involvement in litigation/worker's compensation/disability benefits related to the study parameters
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Advanced Gynecology Specialists of Augusta, LLC

Evans, Georgia, 30809, United States

Location

CT Dermatology PC

Fruitland, Idaho, 83619, United States

Location

Related Publications (1)

  • Thornfeldt CR, Thaxton PM, Hornfeldt CS. A Six-week Low-level Laser Therapy Protocol is Effective for Reducing Waist, Hip, Thigh, and Upper Abdomen Circumference. J Clin Aesthet Dermatol. 2016 Jun;9(6):31-5. Epub 2016 Jun 1.

Results Point of Contact

Title
Elvira Walls, Clinical Consultant
Organization
Regulatory Insight, Inc.

Study Officials

  • Carl R Thornfeldt, MD

    PRINCIPAL INVESTIGATOR
  • Paul M Thaxton, MD

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 7, 2014

First Posted

April 9, 2014

Study Start

October 1, 2013

Primary Completion

November 1, 2014

Study Completion

November 1, 2014

Last Updated

February 2, 2016

Results First Posted

February 2, 2016

Record last verified: 2015-12

Locations